I’ve now contacted Novartis directly and reached out to a national transplant organization to push for change on everolimus access for heart-transplant patients. Your 4,000+ signatures show this isn’t just “one patient with a problem” — it’s a community that cares. Please keep sharing, especially with transplant families, nurses, and anyone in healthcare or policy